Search

Displaying results 6591 - 6600 of 8974 in total
  1. Drug

    VG161

    go.drugbank.com/drugs/DB18469
    Investigational

    VG161 is an oncolytic virus therapy under investigation for the treatment of cholangiocarcinoma.

  2. Drug

    Avagacestat

    go.drugbank.com/drugs/DB11893
    Investigational

    Avagacestat has been investigated for the basic science and treatment of Alzheimer Disease.

  3. Drug

    Tanezumab

    go.drugbank.com/drugs/DB12335
    Investigational

    Tanezumab has been investigated for the treatment of Osteoarthritis, Knee and Neuralgia, Postherpetic.

  4. Drug

    E-7820

    go.drugbank.com/drugs/DB12505
    Investigational

    E7820 has been investigated for the treatment of Colon Cancer and Rectal Cancer.

  5. Drug

    Apaziquone

    go.drugbank.com/drugs/DB12593
    Investigational

    Apaziquone has been investigated for the treatment of Bladder Cancer and Bladder Neoplasms.

  6. Drug

    Brolamfetamine

    go.drugbank.com/drugs/DB01484
    ExperimentalIllicit

    Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
  7. Drug

    CRx-119

    go.drugbank.com/drugs/DB05688
    Experimental

    CRx-119 is a novel synergistic combination drug candidate discovered using the CombinatoRx combination High Throughput Screening (cHTS(TM)) technology with potential therapeutic use in a broad range of

  8. Drug

    EHC18

    go.drugbank.com/drugs/DB05114
    Experimental

    EHC18 is an immune regulation medicine. It is a broad spectrum of specific HCV proteins.

  9. Drug

    Ethyl pyruvate

    go.drugbank.com/drugs/DB05869
    Investigational

    CTI-01 (ethyl pyruvate) is a novel anti-inflammatory agent for the treatment of critical inflammatory conditions.

  10. Drug

    VB2-011

    go.drugbank.com/drugs/DB05411
    Experimental

    According to some preclinical studies, it has a potential to inhibit tumour growth in various cancers including lymphoma and melanoma.